PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, MD, USA. huangru@mail.nih.gov.\', \'Division of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, MD, USA.\', \'Special Pathogens Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, MB, Canada.\', \'Department of Biological Science, Florida State University, Tallahassee, FL, USA.\', \'Division of Preclinical Innovation, National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), Rockville, MD, USA. wzheng@mail.nih.gov.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41587-021-00839-1
?:doi
?:hasPublicationType
?:journal
  • Nature biotechnology
is ?:pmid of
?:pmid
?:pmid
  • 33623157
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 18.252
?:rankingScore_hIndex
  • 377
?:title
  • Biological activity-based modeling identifies antiviral leads against SARS-CoV-2.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all